(Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly ...
“Molecular diagnostics have become indispensable in clinical settings,” says a senior analyst. “The rapid expansion of ...
Story continues below this ad We have advanced significantly forward. The RT-PCR test has always been resource-intensive. So we created the device, COVIRAP, which could take the sample, the nasal or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback